(S (NP-SBJ (NN Cytomegalovirus)) (VP (VBZ modulates) (NP (NN interleukin-6) (NN gene) (NN expression))) (. .))
(S (NP-SBJ (NP (NNS Complications)) (PP-TMP (IN after) (NP (NN lung) (NN transplantation)))) (VP (VBP include) (NP-COOD (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN rejection)))) (CC and) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (NP (NN infection)) (, ,) (PP (RB particularly) (IN with) (NP (NP (NN cytomegalovirus)) (PRN (-LRB- -LRB-) (NP (NN CMV)) (-RRB- -RRB-))))))))) (. .))
(S (NP-SBJ (JJ Several) (JJ recent) (NNS studies)) (VP (VBP have) (VP (VBN suggested) (SBAR (IN that) (S (NP-SBJ-20 (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -6)) (VP (MD may) (VP (VB be) (VP (VBN used) (NP-21 (-NONE- *-20)) (S (NP-SBJ (-NONE- *-21)) (VP (TO to) (VP (VB detect) (NP (NP-COOD (CC both) (NP (NN infection)) (CC and) (NP (NN rejection))) (PP-TMP (IN after) (NP (NN lung) (NN transplantation)))))))))))))) (. .))
(S (IN In) (NP (NN addition)) (, ,) (NP-SBJ (NN IL-6)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN bronchiolitis) (NNS obliterans))) (PP-TMP (IN after) (NP (NN transplantation))))))) (. .))
(S (SBAR (IN Because) (S (NP-SBJ-22 (NN CMV)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN associated) (NP (-NONE- *-22)) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN bronchiolitis) (NNS obliterans))) (PP-TMP (IN after) (NP (NN transplantation))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD determined) (SBAR (IN whether) (S (NP-SBJ (NN CMV)) (VP (VBZ induces) (NP (NN IL-6) (NN gene) (NN expression)))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (NN CMV) (NN infection)) (VP (VBD increased) (NP (NP-COOD (CC both) (NP (NN IL-6) (NN protein)) (CC and) (NP (NP (-NONE- *?*)) (NN mRNA))) (PP (IN in) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)))))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (DT the) (NN CMV) (JJ immediate) (JJ early) (CD 1) (NN gene) (NN product)) (VP (VBD increased) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN IL-6) (NN promoter)))))))) (. .))
(S (NP-SBJ (NP (DT This) (NN effect)) (PP (IN of) (NP (DT the) (NN CMV) (JJ immediate) (JJ early) (CD 1) (NN gene) (NN product)))) (VP (VBD was) (ADJP-PRD (JJ dependent) (PP (IN upon) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ specific) (NN transcription) (NN factor) (NN binding) (NNS sites))) (PP (IN in) (NP (DT the) (NN IL-6) (NN promoter))))))) (. .))
(S (NP-SBJ (DT These) (NNS studies)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NN CMV)) (VP (MD may) (VP (VB be) (NP-PRD (NP (DT an) (JJ important) (NN cofactor)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP-COOD (NP (NN rejection)) (CC and) (NP (NN infection)))) (PP-TMP (IN after) (NP (NN transplantation))) (PP (IN through) (NP (NP (PRP$ its) (NNS effects)) (PP (IN on) (NP (NN IL-6))))))))))))) (. .))
